Darius Moradpour
Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
Radu P, Becchetti C, Schropp J, Schmid P, Künzler-Heule P, Mertens J, Moradpour D, Mullhaupt B, Semela D, Negro F, Heim M, Clerc O, Roelens M, Keiser O, Berzigotti A, Swiss Hepatitis C Cohort Study. Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection. Cancers (Basel) 2024; 16
18.07.2024Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
18.07.2024Cancers (Basel) 2024; 16
Radu Pompilia, Becchetti Chiara, Schropp Jonas, Schmid Patrick, Künzler-Heule Patrizia, Mertens Joachim C, Moradpour Darius, Mullhaupt Beat, Semela David, Negro Francesco, Heim Markus H, Clerc Olivier F, Roelens Maroussia, Keiser Olivia, Berzigotti Annalisa, Swiss Hepatitis C Cohort Study
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Muellhaupt B, Meier M, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Med Wkly 2024; 154:3698.
24.06.2024Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
24.06.2024Swiss Med Wkly 2024; 154:3698
Moschouri Eleni, Salemme Gloria, Baserga Adriana, Cerny Andreas, Deibel Ansgar, Muellhaupt Beat, Meier Marie-Anne, Bernsmeier Christine, Ongaro Marie, Negro Francesco, Grosjean Marielle, Clerc Olivier F, Künzler-Heule Patrizia, Semela David, Hobi Gabriel, Stickel Felix, Mathieu Adeline, Mdawar-Bailly Elise, Faouzi Mohamed, Moradpour Darius, Fraga Montserrat
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.
Saadat A, Gouttenoire J, Ripellino P, Semela D, Amar S, Frey B, Fontana S, Mdawar-Bailly E, Moradpour D, Fellay J, Fraga M, HEV Human Genetics Collaborators. Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E. Hepatology 2023
08.12.2023Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E.
08.12.2023Hepatology 2023
Saadat Ali, Gouttenoire Jérôme, Ripellino Paolo, Semela David, Amar Soraya, Frey Beat M, Fontana Stefano, Mdawar-Bailly Elise, Moradpour Darius, Fellay Jacques, Fraga Montserrat, HEV Human Genetics Collaborators
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue
Vieira Barbosa J, Moradpour D, Weber A, Lenggenhager D, Sempoux C, Mathurin P, Louvet A, Artru F, Gouttenoire J, Neuweiler J, Cathomas G, Montani M, Semela D, Filipowicz Sinnreich M, Brunner F, Mullhaupt B, Fraga M. Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue. Swiss Med Wkly 2021; 151:w20502.
04.05.2021Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue
04.05.2021Swiss Med Wkly 2021; 151:w20502
Vieira Barbosa Joana, Moradpour Darius, Weber Achim, Lenggenhager Daniela, Sempoux Christine, Mathurin Philippe, Louvet Alexandre, Artru Florent, Gouttenoire Jérôme, Neuweiler Jörg, Cathomas Gieri, Montani Matteo, Semela David, Filipowicz Sinnreich Magdalena, Brunner Felix, Mullhaupt Beat, Fraga Montserrat
Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Bobzin C, Semmo N, Semela D, Scheidegger C, Rauch A, Negro F, Moradpour D, Mäschli B, Lavanchy D, Künzler-Heule P, Keiser O, Fraga Christinet M, Cerny A, Bruggmann P, Bösiger C, Thurnheer M. Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C. Swiss Medical Forum 2021; 21:184-186.
17.03.2021Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
17.03.2021Swiss Medical Forum 2021; 21:184-186
Bobzin Carina, Semmo Nasser, Semela David, Scheidegger Claude, Rauch Andri, Negro Francesco, Moradpour Darius, Mäschli Bettina, Lavanchy D, Künzler-Heule Patrizia, Keiser Olivia, Fraga Christinet Montserrat, Cerny Andreas, Bruggmann Philip, Bösiger Christophe, Thurnheer Maria Christine
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Roelens M, Keiser O, Negro F, Junker C, Semela D, Clerc O, Mullhaupt B, Schmid P, Semmo N, Cerny A, Moradpour D, Bertisch B, Swiss Hepatitis C Cohort Study. All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS). Open Forum Infect Dis 2020; 7:ofaa308.
25.07.2020All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
25.07.2020Open Forum Infect Dis 2020; 7:ofaa308
Roelens Maroussia, Keiser Olivia, Negro Francesco, Junker Christoph, Semela David, Clerc Olivier, Mullhaupt Beat, Schmid Patrick, Semmo Nasser, Cerny Andreas, Moradpour Darius, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Brezzi M, Keiser O, Negro F, Semela D, Mullhaupt B, Semmo N, Terziroli Beretta-Piccoli B, Moradpour D, Roelens M, Bertisch B, Swiss Hepatitis C Cohort Study. Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study. PloS one 2019; 14:e0218706.
24.06.2019Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
24.06.2019PloS one 2019; 14:e0218706
Brezzi Matteo, Keiser Olivia, Negro Francesco, Semela David, Mullhaupt Beat, Semmo Nasser, Terziroli Beretta-Piccoli Benedetta, Moradpour Darius, Roelens Maroussia, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
Terziroli Beretta-Piccoli B, Muratori L, Vergani D, Mieli-Vergani G, Moradpour D, Semela D, Semmo N, Mertens J, Cerny A, Melidona L, Tesei C, Silvestri T, Grondona A, Deleonardi G, Di Bartolomeo C, Swiss Hepatitis C Cohort Study. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. J Autoimmun 2019; 102:89-95.
30.04.2019Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents
30.04.2019J Autoimmun 2019; 102:89-95
Terziroli Beretta-Piccoli Benedetta, Muratori Luigi, Vergani Diego, Mieli-Vergani Giorgina, Moradpour Darius, Semela David, Semmo Nasser, Mertens Joachim, Cerny Andreas, Melidona Laura, Tesei Cinzia, Silvestri Tania, Grondona Ana Gabriela, Deleonardi Gaia, Di Bartolomeo Claudia, Swiss Hepatitis C Cohort Study
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
Bertisch B, Keiser O, Moradpour D, Zehnder C, Marinucci F, Roelens M, Moriggia A, Clerc O, Giudici F, Schmid P, Künzler-Heule P, Ottiger C, Mullhaupt B, Negro F, Brezzi M, Swiss Hepatitis C Cohort Study. Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?. Clin Infect Dis 2019
03.04.2019Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
03.04.2019Clin Infect Dis 2019
Bertisch Barbara, Keiser Olivia, Moradpour Darius, Zehnder Cinzia, Marinucci Francesco, Roelens Maroussia, Moriggia Alberto, Clerc Olivier, Giudici Fabio, Schmid Patrick, Künzler-Heule Patrizia, Ottiger Cornelia, Mullhaupt Beat, Negro Francesco, Brezzi Matteo, Swiss Hepatitis C Cohort Study
Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland
Sahli R, Fraga M, Moradpour D, Gouttenoire J. Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland. J Hepatol 2019
22.02.2019Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland
22.02.2019J Hepatol 2019
Sahli Roland, Fraga Montserrat, Moradpour Darius, Gouttenoire Jérôme
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
Fraga M, Sahli R, Greub G, Telenti A, Aubert V, Terziroli Beretta-Piccoli B, Stickel F, Semela D, Ripellino P, Mullhaupt B, Brunner F, Bihl F, Moulin H, Doerig C, Moradpour D. Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland. Liver Int 2017
23.08.2017Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
23.08.2017Liver Int 2017
Fraga Montserrat, Sahli Roland, Greub Gilbert, Telenti Amalio, Aubert Vincent, Terziroli Beretta-Piccoli Benedetta, Stickel Felix, Semela David, Ripellino Paolo, Mullhaupt Beat, Brunner Felix, Bihl Florian, Moulin Hervé, Doerig Christopher, Moradpour Darius
Visualization of hepatitis E virus RNA and proteins in the human liver
Lenggenhager D, Moradpour D, Sempoux C, Mullhaupt B, Rubbia-Brandt L, Terracciano L, Sahli R, Fraga M, Aepli P, Hürlimann S, Neuweiler J, Semela D, Kreutzer S, Honcharova-Biletska H, Bawohl M, Malehmir M, Gouttenoire J, Weber A. Visualization of hepatitis E virus RNA and proteins in the human liver. J Hepatol 2017; 67:471-479.
13.04.2017Visualization of hepatitis E virus RNA and proteins in the human liver
13.04.2017J Hepatol 2017; 67:471-479
Lenggenhager Daniela, Moradpour Darius, Sempoux Christine, Mullhaupt Beat, Rubbia-Brandt Laura, Terracciano Luigi, Sahli Roland, Fraga Montserrat, Aepli Patrick, Hürlimann Sandra, Neuweiler Jörg, Semela David, Kreutzer Susanne, Honcharova-Biletska Hanna, Bawohl Marion, Malehmir Mohsen, Gouttenoire Jérôme, Weber Achim
A systematic review and meta-analysis of HCV clearance
Gauthiez E, Moradpour D, Mullhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P, Malinverni R, Heim M, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
30.03.2017A systematic review and meta-analysis of HCV clearance
30.03.2017Liver Int 2017; 37:1431-1445
Gauthiez Emeline, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Semela David, Semmo Nasser, Villard Jean, Bibert Stéphanie, Bochud Pierre-Yves, Malinverni Raffaele, Heim Markus H, Habfast-Robertson Ines, Rüeger Sina, Kutalik Zoltán, Aubert Vincent, Berg Thomas, Cerny Andreas, Gorgievski Meri, George Jacob, Swiss Hepatitis C Cohort Study
Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study
Béguelin C, Wandeler G, Rauch A, Atkinson A, Calmy A, Schmid P, Bernasconi E, Battegay M, Günthard H, Cavassini M, Lüthi A, Suter-Riniker F, Sahli R, Moradpour D, Friolet N. Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study. Clin Infect Dis 2017
11.02.2017Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study
11.02.2017Clin Infect Dis 2017
Béguelin Charles, Wandeler Gilles, Rauch Andri, Atkinson Andrew, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Cavassini Matthias, Lüthi Alexander, Suter-Riniker Franziska, Sahli Roland, Moradpour Darius, Friolet Nicole
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis
Ambregna S, Dumortier J, Frossard J, Kull E, Meny B, Moradpour D, Prat F, Vanbiervliet G, Thevenot T, Vuitton D, Bresson-Hadni S, Deprez P, Boytchev I, Koch S, Sulz M, Grüner B, Öztürk S, Chevaux J, Sulima M, De Gottardi A, Napoléon B, Abergel A, Bichard P, Vuitton L. A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis. Expert Rev Anti Infect Ther 2016; 15:79-88.
07.11.2016A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis
07.11.2016Expert Rev Anti Infect Ther 2016; 15:79-88
Ambregna Sylvain, Dumortier Jerome, Frossard Jean-Louis, Kull Eric, Meny Bernard, Moradpour Darius, Prat Fréderic, Vanbiervliet Geoffroy, Thevenot Thierry, Vuitton Dominique Angèle, Bresson-Hadni Solange, Deprez Pierre, Boytchev Isabelle, Koch Stéphane, Sulz Michael, Grüner Beate, Öztürk Sümeyra, Chevaux Jean-Baptiste, Sulima Małgorzata, De Gottardi Andrea, Napoléon Bertrand, Abergel Armand, Bichard Philippe, Vuitton Lucine
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
Béguelin C, Wandeler G, Rauch A, Furrer H, Braun D, Calmy A, Schmid P, Bernasconi E, Battegay M, Günthard H, Cavassini M, Lüthi A, Suter-Riniker F, Sahli R, Moradpour D. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. J Hepatol 2016; 66:297-303.
14.10.2016Hepatitis delta-associated mortality in HIV/HBV-coinfected patients
14.10.2016J Hepatol 2016; 66:297-303
Béguelin Charles, Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Braun Dominique L, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Cavassini Matthias, Lüthi Alexander, Suter-Riniker Franziska, Sahli Roland, Moradpour Darius
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
29.06.2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
29.06.2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
23.12.2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
23.12.2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Clinical significance of the CCR5delta32 allele in hepatitis C
Morard I, Negro F, Bochud P, Pascarella S, Semela D, Mullhaupt B, Moradpour D, Malinverni R, Heim M, Gorgievski M, De Gottardi A, Cerny A, Mangia A, Calmy A, Clément S, Swiss Hepatitis C Cohort Study Group. Clinical significance of the CCR5delta32 allele in hepatitis C. PloS one 2014; 9:e106424.
05.09.2014Clinical significance of the CCR5delta32 allele in hepatitis C
05.09.2014PloS one 2014; 9:e106424
Morard Isabelle, Negro Franco, Bochud Pierre-Yves, Pascarella Stéphanie, Semela David, Mullhaupt Beat, Moradpour Darius, Malinverni Raffaele, Heim Markus, Gorgievski Meri, De Gottardi Andrea, Cerny Andrea, Mangia Alessandra, Calmy Alexandra, Clément Sophie, Swiss Hepatitis C Cohort Study Group
Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1
Stickel F, Worni M, Pache I, Moradpour D, Helbling B, Borovicka J, Gerlach T. Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1. Am J Gastroenterol 2013; 108:1176-8.
01.07.2013Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1
01.07.2013Am J Gastroenterol 2013; 108:1176-8
Stickel Felix, Worni Mathias, Pache Isabelle, Moradpour Darius, Helbling Beat, Borovicka Jan, Gerlach Tilman J